Pharmaconex is part of the Informa Markets Division of Informa PLC


Pharmaconex Pharma Awards

Pharma awards represent recognition of excellence and represent the amount of efforts exerted in developing the industry. It covers multiple categories representing innovation, quality, efforts exerted to transform the industry and contribute to enhancing people's lives. 

                              Awarded Categories

Excellence in API Development

Recognize companies that have demonstrated outstanding achievements in the research, development, and production of high-quality and innovative Active Pharmaceutical Ingredients. Participants will be evaluated based on the novelty and efficacy of their APIs, their contribution to improved patient outcomes, cost-effectiveness, and adherence to safety and quality standards.

Excellence in Packaging and Drug Delivery

Acknowledge companies that have excelled in developing innovative and sustainable packaging solutions and drug delivery systems. Participants will be assessed on factors such as ease of use, patient compliance, environmental impact, and the ability to enhance drug stability and efficacy.

Excellence in Machinery

Recognize Honor companies that have significantly advanced manufacturing machinery and equipment used in pharmaceutical production processes. Participants will be judged on their machinery's efficiency, reliability, scalability, and safety, as well as their ability to streamline manufacturing processes and reduce production costs.

Excellence in Digital Transformation

Recognize companies that have successfully implemented digital technologies and data-driven strategies to optimize various aspects of their pharmaceutical operations. Participants will be evaluated based on their use of digital tools for research and development, supply chain management, quality control, customer engagement, and overall business efficiency.

Excellence in Sustainability

Recognize companies that demonstrate a strong commitment to sustainable practices and environmentally responsible initiatives in the pharmaceutical industry. Participants will be assessed on their efforts to reduce carbon footprint, minimize waste generation, promote eco-friendly manufacturing processes, and contribute positively to society and the environment.